Physician profile
Elliot C Lederman
NPI 1134284284
$731.90
in general payments reported to CMS, 2019-2025
14 companies · $138 in 2025
The $138 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $97.74 · 2020: $104 · 2021: $166 · 2022: $58.57 · 2023: $63.78 · 2024: $104 · 2025: $138.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $306.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $305.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $213.13 | 2019-2024 | Jardiance |
| Lilly USA, LLC | $151.85 | 2021-2025 | Jardiance, Mounjaro |
| Exact Sciences Corporation | $103.47 | 2024-2025 | Cologuard Collection Kit |
| Merck Sharp & Dohme LLC | $44.96 | 2020-2021 | |
| Amgen INC. | $42.12 | 2024-2025 | Otezla, Repatha, Repatha |
| Abbvie INC. | $41.02 | 2019-2021 | |
| Horizon Therapeutics Plc | $36.12 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $26.46 | 2019-2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $23.76 | 2021 | |
| Amarin Pharma, INC. | $20.36 | 2020 | |
| Shire North American Group INC | $17.50 | 2019 | |
| Allergan, INC. | $11.15 | 2020 |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Elliot Lederman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.